164 related articles for article (PubMed ID: 34558092)
1. Evaluation of published population pharmacokinetic models to inform tacrolimus dosing in adult heart transplant recipients.
Kirubakaran R; Hennig S; Maslen B; Day RO; Carland JE; Stocker SL
Br J Clin Pharmacol; 2022 Feb; 88(4):1751-1772. PubMed ID: 34558092
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of a population pharmacokinetic model to inform tacrolimus therapy in heart transplant recipients.
Kirubakaran R; Uster DW; Hennig S; Carland JE; Day RO; Wicha SG; Stocker SL
Br J Clin Pharmacol; 2023 Mar; 89(3):1162-1175. PubMed ID: 36239542
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Published Population Pharmacokinetic Models to Inform Tacrolimus Therapy in Adult Lung Transplant Recipients.
Kirubakaran R; Singh RM; Carland JE; Day RO; Stocker SL
Ther Drug Monit; 2024 May; ():. PubMed ID: 38723160
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus Therapy in Adult Heart Transplant Recipients: Evaluation of a Bayesian Forecasting Software.
Kirubakaran R; Stocker SL; Carlos L; Day RO; Carland JE
Ther Drug Monit; 2021 Dec; 43(6):736-746. PubMed ID: 34126624
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
Brooks E; Tett SE; Isbel NM; Staatz CE
Clin Pharmacokinet; 2016 Nov; 55(11):1295-1335. PubMed ID: 27138787
[TBL] [Abstract][Full Text] [Related]
6. Prediction of tacrolimus dosage in the early period after heart transplantation: a population pharmacokinetic approach.
Han Y; Zhou H; Cai J; Huang J; Zhang J; Shi SJ; Liu YN; Zhang Y
Pharmacogenomics; 2019 Jan; 20(1):21-35. PubMed ID: 30730287
[TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation.
Monchaud C; de Winter BC; Knoop C; Estenne M; Reynaud-Gaubert M; Pison C; Stern M; Kessler R; Guillemain R; Marquet P; Rousseau A
Clin Pharmacokinet; 2012 Mar; 51(3):175-86. PubMed ID: 22339449
[TBL] [Abstract][Full Text] [Related]
8. Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients.
Cai X; Li R; Sheng C; Tao Y; Zhang Q; Zhang X; Li J; Shen C; Qiu X; Wang Z; Jiao Z
Eur J Pharm Sci; 2020 Mar; 145():105237. PubMed ID: 32001346
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation.
Benkali K; Rostaing L; Premaud A; Woillard JB; Saint-Marcoux F; Urien S; Kamar N; Marquet P; Rousseau A
Clin Pharmacokinet; 2010 Oct; 49(10):683-92. PubMed ID: 20818834
[TBL] [Abstract][Full Text] [Related]
10. External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients.
Zhao CY; Jiao Z; Mao JJ; Qiu XY
Br J Clin Pharmacol; 2016 May; 81(5):891-907. PubMed ID: 26574188
[TBL] [Abstract][Full Text] [Related]
11. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.
Zhang HX; Sheng CC; Liu LS; Luo B; Fu Q; Zhao Q; Li J; Liu YF; Deng RH; Jiao Z; Wang CX
Br J Clin Pharmacol; 2019 Apr; 85(4):746-761. PubMed ID: 30597603
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis of tacrolimus in Chinese cardiac transplant recipients.
Gong Y; Yang M; Sun Y; Li J; Lu Y; Li X
Eur J Hosp Pharm; 2020 Mar; 27(e1):e12-e18. PubMed ID: 32296499
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Bayesian Forecasting Methods for Prediction of Tacrolimus Exposure Using Samples Taken on Two Occasions in Adult Kidney Transplant Recipients.
Brooks E; Tett SE; Isbel NM; McWhinney B; Staatz CE
Ther Drug Monit; 2021 Apr; 43(2):238-246. PubMed ID: 32932413
[TBL] [Abstract][Full Text] [Related]
14. Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes.
Hu C; Yin WJ; Li DY; Ding JJ; Zhou LY; Wang JL; Ma RR; Liu K; Zhou G; Zuo XC
Eur J Clin Pharmacol; 2018 Nov; 74(11):1437-1447. PubMed ID: 30019212
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
Benkali K; Prémaud A; Picard N; Rérolle JP; Toupance O; Hoizey G; Turcant A; Villemain F; Le Meur Y; Marquet P; Rousseau A
Clin Pharmacokinet; 2009; 48(12):805-16. PubMed ID: 19902988
[TBL] [Abstract][Full Text] [Related]
16. Population Pharmacokinetic Modeling Combined With Machine Learning Approach Improved Tacrolimus Trough Concentration Prediction in Chinese Adult Liver Transplant Recipients.
Li ZR; Li RD; Niu WJ; Zheng XY; Wang ZX; Zhong MK; Qiu XY
J Clin Pharmacol; 2023 Mar; 63(3):314-325. PubMed ID: 36097320
[TBL] [Abstract][Full Text] [Related]
17. Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf.
Woillard JB; de Winter BC; Kamar N; Marquet P; Rostaing L; Rousseau A
Br J Clin Pharmacol; 2011 Mar; 71(3):391-402. PubMed ID: 21284698
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review.
Kirubakaran R; Stocker SL; Hennig S; Day RO; Carland JE
Clin Pharmacokinet; 2020 Nov; 59(11):1357-1392. PubMed ID: 32783100
[TBL] [Abstract][Full Text] [Related]
19. Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients.
Willis C; Staatz CE; Tett SE
Ther Drug Monit; 2003 Apr; 25(2):158-66. PubMed ID: 12657909
[TBL] [Abstract][Full Text] [Related]
20. Clinical Pharmacokinetics of Once-Daily Tacrolimus in Solid-Organ Transplant Patients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2015 Oct; 54(10):993-1025. PubMed ID: 26038096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
